Microvolt T-wave alternans in end-stage renal disease patients - Associations with uremic cardiomyopathy

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 3, 2011, Pages 519-527

  Patel, Rajan K ^a,b   Mark, Patrick B ^a,b   Halliday, Crawford ^b   Steedman, Tracey ^b   Dargie, Henry J ^b   Cobbe, Stuart M ^a   Jardine, Alan G ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; WARFARIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOMYOPATHY; DIABETES MELLITUS; DIALYSIS; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROVOLT T WAVE ALTERNANS; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEAL DIALYSIS; T WAVE; UREMIC CARDIOMYOPATHY; VASCULAR DISEASE;

ADULT; AGED; CARDIOMYOPATHIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SCOTLAND; TACHYCARDIA, VENTRICULAR; UREMIA;

EID: 79952995314     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06370710     Document Type: Article

References (36)

1. U.S. Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2009
2. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11: 1277-1285, 1996 (Pubitemid 26241416)
3. Herzog CA, Strief JW, Collins AJ, Gilbertson DT: Cause-specific mortality of dialysis patients after coronary revascularization: Why don't dialysis patients have better survival after coronary intervention? Nephrol Dial Transplant 23: 2629-2633, 2008
4. Bleyer AJ, Russell GB, Satko SG: Sudden and cardiac death rates in hemodialysis patients. Kidney Int 55: 1553-1559, 1999 (Pubitemid 29157156)
5. Zoccali C, Mallamaci F, Tripepi G, Parlongo S, Cutrupi S, Benedetto FA, Cataliotti A, Malatino LS: Norepinephrine and concentric hypertrophy in patients with end-stage renal disease. Hypertension 40: 41-46, 2002 (Pubitemid 34755977)
6. Rodriguez-Benot A, Martin-Malo A, Alvarez-Lara MA, Rodriguez M, Aljama P: Mild hyperphosphatemia and mortality in hemodialysis patients. Am J Kidney Dis 46: 68-77, 2005 (Pubitemid 40848434)
7. Stenvinkel P: Inflammation in end-stage renal disease: The hidden enemy. Nephrology (Carlton) 11: 36-41, 2006
8. Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Gronhagen-Riska C, De Lima JJ, Lins R, Mayer G, Mc-Mahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Suleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wuthrich RP, Gottlow M, Johnsson E, Zannad F: Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360: 1395-1407, 2009
9. Cice G, Ferrara L, D'Andrea A, D'Isa S, Di Benedetto A, Cittadini A, Russo PE, Golino P, Calabro R: Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial. J Am Coll Cardiol 41: 1438-1444, 2003 (Pubitemid 36543357)
10. Zannad F, Kessler M, Lehert P, Grunfeld JP, Thuilliez C, Leizorovicz A, Lechat P: Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies. Kidney Int 70: 1318-1324, 2006 (Pubitemid 44435184)
11. Estes NA, III, Michaud G, Zipes DP, El Sherif N, Venditti FJ, Rosenbaum DS, Albrecht P, Wang PJ, Cohen RJ: Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias. Am J Cardiol 80: 1314-1318, 1997 (Pubitemid 27513332)
12. Richter S, Duray G, Hohnloser SH: How to analyze T-wave alternans. Heart Rhythm 2: 1268-1271, 2005 (Pubitemid 41614177)
13. Bloomfield DM, Hohnloser SH, Cohen RJ: Interpretation and classification of microvolt T wave alternans tests. J Cardiovasc Electrophysiol 13: 502-512, 2002 (Pubitemid 34494273)
14. Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB, Kaufman ES, Davidenko JM, Shinn TS, Fontaine JM: Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47: 456-463, 2006 (Pubitemid 43063271)
15. Gehi AK, Stein RH, Metz LD, Gomes JA: Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: A meta-analysis. J Am Coll Cardiol 46: 75-82, 2005 (Pubitemid 40905133)
16. Furlanello F, Galanti G, Manetti P, Capalbo A, Pucci N, Michelucci A, Marangoni D, Terrasi F, Pettinati G, Cappato R: Microvolt T-wave alternans as predictor of electrophysiological testing results in professional competitive athletes. Ann Noninvasive Electrocardiol 9: 201-206, 2004 (Pubitemid 39044070)
17. Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, Chung ES, Menon S, Nallamothu BK, Chan PS: Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 47: 1820-1827, 2006
18. Molon G, Costa A, Bertolini L, Zenari L, Arcaro G, Barbieri E, Targher G: Relationship between abnormal microvolt T-wave alternans and poor glycemic control in type 2 diabetic patients. Pacing Clin Electrophysiol 30: 1267-1272, 2007 (Pubitemid 47493130)
19. Scottish Renal Registry. Available at: www.srr.scot.nhs.uk. Accessed February 12, 2010
20. Stewart GA, Mark PB, Johnston N, Foster JE, Cowan M, Rodger RS, Dargie HJ, Jardine AG: Determinants of hypertension and left ventricular function in end stage renal failure: A pilot study using cardiovascular magnetic resonance imaging. Clin Physiol Funct Imaging 24: 387-393, 2004 (Pubitemid 39529877)
21. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU: Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 17: 323-329, 2003 (Pubitemid 36259246)
22. Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F: Prognostic value of T-wave alternans in patients with heart failure due to non-ischemic cardiomyopathy: Results of the ALPHA Study. J Am Coll Cardiol 50: 1896-1904, 2007
23. Kern MJ, Lerman A, Bech JW, De Bruyne B, Eeckhout E, Fearon WF, Higano ST, Lim MJ, Meuwissen M, Piek JJ, Pijls NH, Siebes M, Spaan JA: Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: A scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation 114: 1321-1341, 2006 (Pubitemid 44402059)
24. Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, Erzengin F, Tepe S: Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant 20: 760-767, 2005 (Pubitemid 40520654)
25. Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT: Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 68: 818-825, 2005 (Pubitemid 43323139)
26. Robin J, Weinberg K, Tiongson J, Carnethon M, Reddy M, Ciaccio C, Quadrini M, Hsu J, Fan J, Choi P, Kadish A, Gold-berger J, Passman R: Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverterdefibrillator recipients. Heart Rhythm 3: 1196-1201, 2006 (Pubitemid 44464149)
27. Chow T, Kereiakes DJ, Onufer J, Woelfel A, Gursoy S, Peterson BJ, Brown ML, Pu W, Benditt DG: Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol 52: 1607-1615, 2008
28. Gold MR, Ip JH, Costantini O, Poole JE, McNulty S, Mark DB, Lee KL, Bardy GH: Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: Primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation 118: 2022-2028, 2008
29. Francis D, Lane R, Mayet J, Foale RA, Thom S, Peters NS: Microvolt T wave alternans in patients with hypertension and left ventricular hypertrophy. J Hum Hypertens 15[Suppl 1]: S95-S96, 2001 (Pubitemid 32904121)
30. Krane V, Heinrich F, Meesmann M, Olschewski M, Lilienthal J, Angermann C, Stork S, Bauersachs J, Wanner C, Frantz S: Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol 4: 394-400, 2009
31. Pastore JM, Girouard SD, Laurita KR, Akar FG, Rosenbaum DS: Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 99: 1385-1394, 1999 (Pubitemid 29129926)
32. Wyse DG, Friedman PL, Brodsky MA, Beckman KJ, Carlson MD, Curtis AB, Hallstrom AP, Raitt MH, Wilkoff BL, Greene HL: Life-threatening ventricular arrhythmias due to transient or correctable causes: High risk for death in follow-up. J Am Coll Cardiol 38: 1718-1724, 2001 (Pubitemid 33065460)
33. U.S. Renal Data System: USRDS 2002 Annual Data Report. Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2002
34. Sharma R, Pellerin D, Gaze DC, Gregson H, Streather CP, Collinson PO, Brecker SJ: Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant 20: 2207-2214, 2005 (Pubitemid 41510099)
35. Kaufman ES, Bloomfield DM, Steinman RC, Namerow PB, Costantini O, Cohen RJ, Bigger JT Jr: "Indeterminate" micro-volt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 48: 1399-1404, 2006 (Pubitemid 44444863)
36. Chan PS, Bartone C, Booth T, Kereiakes D, Chow T: Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal. Am Heart J 153: 523-529, 2007 (Pubitemid 46440683)